These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 2021689

  • 1. [Activation of N-myc oncogene and associated genes to chemoresistance, prognostic value for neuroblastoma].
    Bénard J, Bourhis J, Riou G.
    Bull Cancer; 1991 Jan; 78(1):91-7. PubMed ID: 2021689
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe ST, Valentine MB, Komuro H.
    Cancer Res; 1995 Feb 15; 55(4):721-6. PubMed ID: 7850780
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
    Sivak LE, Tai KF, Smith RS, Dillon PA, Brodeur GM, Carroll WL.
    Oncogene; 1997 Oct 16; 15(16):1937-46. PubMed ID: 9365240
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysis.
    Bénard J, Bourhis J, de Vathaire F, Ferrandis E, Terrier-Lacombe MJ, Lemerle J, Riou G, Hartmann O.
    Prog Clin Biol Res; 1994 Oct 16; 385():111-6. PubMed ID: 7972202
    [Abstract] [Full Text] [Related]

  • 10. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J, Bénard J, DeVathaire F, Wilson GD, Hartmann O, Terrier-Lacombe MJ, Boccon-Gibod L, Lemerle J, Riou G.
    Prog Clin Biol Res; 1991 Oct 16; 366():107-13. PubMed ID: 2068130
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
    Suita S, Tajiri T, Sera Y, Takamatsu H, Mizote H, Nagasaki A, Kurosaki N, Hara T, Okamura J, Miyazaki S, Sugimoto T, Kawakami K, Eguchi H, Tsuneyoshi M.
    J Pediatr Surg; 2000 Dec 16; 35(12):1737-41. PubMed ID: 11101726
    [Abstract] [Full Text] [Related]

  • 13. [Sensibility and specificity of N-myc oncogene with respect to other prognostic factors in 15 neuroblastomas].
    Queizán A, García-Miguel P, Belló MJ, Castresana JC, Rey JA, Pestaña A.
    Cir Pediatr; 1995 Jul 16; 8(3):96-8. PubMed ID: 8527322
    [Abstract] [Full Text] [Related]

  • 14. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS, Gallie BL, DeBoer G, Haddad G, Ikegaki N, Dimitroulakos J, Yeger H, Ling V.
    Clin Cancer Res; 1997 Oct 16; 3(10):1699-706. PubMed ID: 9815553
    [Abstract] [Full Text] [Related]

  • 15. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB, Veenstra M, v Sluis P, Boon K, v Asperen R, Hermus MC, v Schaik BD, Voûte TP, Schwab M, Versteeg R, Caron HN.
    Oncogene; 2002 Mar 27; 21(13):2097-101. PubMed ID: 11960382
    [Abstract] [Full Text] [Related]

  • 16. Amplification of N-myc as a prognostic marker for patients with neuroblastoma.
    Schwab M.
    Semin Cancer Biol; 1993 Feb 27; 4(1):13-8. PubMed ID: 8448374
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.